Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95:20211033.

Article  PubMed  Google Scholar 

Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15–23.

Article  PubMed  PubMed Central  Google Scholar 

Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, et al. Health and racial disparity in breast cancer. Adv Exp Med Biol. 2019;1152:31–49.

Parise CA, Bauer KR, Brown MM, Caggiano V. Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999–2004. Breast J. 2009;15:593–602.

Article  PubMed  Google Scholar 

Karagiannakos A, Adamaki M, Tsintarakis A, Vojtesek B, Fåhraeus R, Zoumpourlis V, et al. Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets. Cancers (Basel). 2022;14:664.

Article  CAS  PubMed  Google Scholar 

Batis N, Brooks JM, Payne K, Sharma N, Nankivell P, Mehanna H. Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation. Adv Drug Deliv Rev. 2021;176:113854.

Article  CAS  PubMed  Google Scholar 

Kasper G, Momen M, Sorice KA, Mayhand KN, Handorf EA, Gonzalez ET, et al. Effect of neighborhood and individual-level socioeconomic factors on breast cancer screening adherence in a multi-ethnic study. BMC Public Health. 2024;24:63.

Article  PubMed  PubMed Central  Google Scholar 

Kamińska M, Ciszewski T, Łopacka-Szatan K, Miotła P, Starosławska E. Breast cancer risk factors. Menopausal. Review. 2015;3:196–202.

Google Scholar 

Akakpo PK, Imbeah EG, Edusei L, Naporo S, Ulzen-Appiah K, Clegg-Lamptey JN, et al. Clinicopathologic characteristics of early-onset breast cancer: a comparative analysis of cases from across Ghana. BMC Womens Health. 2023;23:5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492.

Article  CAS  PubMed  Google Scholar 

Minas TZ, Kiely M, Ajao A, Ambs S. An overview of cancer health disparities: new approaches and insights and why they matter. Carcinogenesis. 2021;42:2–13.

Article  CAS  PubMed  Google Scholar 

Wang F, Shu X, Meszoely I, Pal T, Mayer IA, Yu Z, et al. Overall Mortality After Diagnosis of Breast Cancer in Men vs Women. JAMA Oncol. 2019;5:1589.

Article  PubMed  PubMed Central  Google Scholar 

Lovejoy LA, Shriver CD, Haricharan S, Ellsworth RE. Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer. Int J Environ Res Public Health. 2023;20:2903.

Article  PubMed  PubMed Central  Google Scholar 

Taheri M, Tavakol M, Akbari ME, Almasi-Hashiani A, Abbasi M. Relationship of socio economic status, income, and education with the survival rate of breast cancer: a meta-analysis. Iran J Public Health. 2019;48:1428–38.

PubMed  PubMed Central  Google Scholar 

Roy AM, George A, Attwood K, Alaklabi S, Patel A, Omilian AR, et al. Effect of neighborhood deprivation index on breast cancer survival in the United States. Breast Cancer Res Treat. 2023;202:139–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

LeBlanc G, Lee I, Carretta H, Luo Y, Sinha D, Rust G. Rural-urban differences in breast cancer stage at diagnosis. Womens Health Rep. 2022;3:207–14.

Google Scholar 

Yang C, Lei C, Zhang Y, Zhang J, Ji F, Pan W, et al. Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database. Front Oncol. 2020;10:590643.

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Liang Y, Ye F, Luo D, Jin Y, Li Y, et al. Histologic heterogeneity predicts patient prognosis of <scp>HER2</scp> -positive metastatic breast cancer: A retrospective study based on <scp>SEER</scp> database. Cancer Med. 2023;12:18597–610.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Plichta JK, Rushing CN, Lewis HC, Rooney MM, Blazer DG, Thomas SM, et al. Implications of missing data on reported breast cancer mortality. Breast Cancer Res Treat. 2023;197:177–87.

Article  PubMed  Google Scholar 

Wilson BE, Jacob S, Do V, Amir E, Bray F, Ferlay J, et al. Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact. JCO Glob Oncol. 2021;7:1074–83.

Article  PubMed  Google Scholar 

Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. NCCN guidelines insights: breast cancer, version 1.2017. J Natl Compr Canc Netw. 2017;15:433–51.

Article  PubMed  Google Scholar 

Mu Y, Meng Y, Du Y, Liu X, Zhang J. Clinical characteristics and treatment outcomes of <scp>HER2</scp> mutation and <scp>HER2</scp> fusion in 22 patients with advanced breast cancer. Thorac Cancer. 2023;14:3381–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mukherjee A, Russell R, Chin S-F, Liu B, Rueda OM, Ali HR, et al. Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort. NPJ Breast Cancer. 2018;4:5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xing K, Zhang B, Wang Z, Zhang Y, Chai T, Geng J, et al. Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures. Based on Single-Cell RNA-Seq Data Cells. 2023;12:367.

CAS  PubMed  Google Scholar 

Frebault J, Bergom C, Cortina CS, Shukla ME, Zhang Y, Huang C-C, et al. Invasive Breast Cancer Treatment Patterns in Women Age 80 and Over: A Report from the National Cancer Database. Clin Breast Cancer. 2022;22:49–59.

Article  PubMed  Google Scholar 

Wu Y, Qi Y, Yang J, Yang R, Lui W, Huang Y, et al. Effect of adjuvant chemotherapy on the survival outcomes of elderly breast cancer: A retrospective cohort study based on SEER database. J Evid Based Med. 2022;15:354–64.

Article  PubMed  PubMed Central  Google Scholar 

Ashok Kumar P, Wang D, Huang D, Sivapiragasam A. Adjuvant Chemotherapy in Premenopausal Patients With Hormone-Positive Breast Cancer With a Recurrence Score of 16–25: A Retrospective Analysis Using the National Cancer Database. JCO Precis Oncol. 2024;8:e2300390.

Article  PubMed  Google Scholar 

Piccart MJ, Kalinsky K, Gray R, Barlow WE, Poncet C, Cardoso F, et al. Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust. Ann Oncol. 2021;32:1077–82.

Article  CAS  PubMed  Google Scholar 

Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, et al. Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. J Clin Oncol. 2019;37:423–38.

Article  CAS  PubMed  Google Scholar 

Iranmakani S, Mortezazadeh T, Sajadian F, Ghaziani MF, Ghafari A, Khezerloo D, et al. A review of various modalities in breast imaging: technical aspects and clinical outcomes. Egypt J Radiol Nucl Med. 2020;51:57.

Article  Google Scholar 

Nicosia L, Gnocchi G, Gorini I, Venturini M, Fontana F, Pesapane F, et al. History of Mammography: Analysis of Breast Imaging Diagnostic Achievements over the Last Century. Healthcare. 2023;11:1596.

Article  PubMed  PubMed Central  Google Scholar 

Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening. N Engl J Med. 2005;353:1773–83.

Article  CAS  PubMed  Google Scholar 

Berg WA. Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer. JAMA. 2008;299:2151.

Arti